PAINMATRIX-ER

PAINMATRIX-ER Tablets is an extended-release non-steroidal anti-inflammatory formulation from Orfit Pharmaceutical Pvt. Ltd., designed to provide sustained relief from pain and inflammation with once-daily dosing. It contains Etodolac 600 mg (Extended Release), a well-established NSAID known for its effective analgesic and anti-inflammatory action with improved gastrointestinal tolerability. This extended-release formulation ensures steady drug levels over a prolonged period, making PAINMATRIX-ER especially beneficial for chronic inflammatory conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and long-standing musculoskeletal pain. Etodolac works by inhibiting prostaglandin synthesis, thereby reducing pain, swelling, and joint stiffness while improving mobility and daily functioning. PAINMATRIX-ER Tablets help provide consistent, all-day pain control, reducing the need for frequent dosing and improving patient compliance. Manufactured under stringent quality and safety standards, PAINMATRIX-ER reflects Orfit Pharmaceutical Pvt. Ltd.’s commitment to delivering reliable, effective, and patient-centric solutions for long-term pain and inflammation management.